Applied DNA Sciences Inc EPS - Earnings per Share 2010-2025 | APDN
Applied DNA Sciences Inc eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Applied DNA Sciences Inc Annual EPS |
| 2024 |
$-1,364.32 |
| 2023 |
$-11,401.80 |
| 2022 |
$-13,943.03 |
| 2021 |
$-31,034.48 |
| 2020 |
$-49,775.11 |
| 2019 |
$-145,277.40 |
| 2018 |
$-237,781.10 |
| 2017 |
$-0.49 |
| 2016 |
$-0.51 |
| 2015 |
$-0.63 |
| 2014 |
$-0.97 |
| 2013 |
$-1.51 |
| 2012 |
$-0.74 |
| 2011 |
$-0.03 |
| 2010 |
$-0.03 |
| 2009 |
$0.01 |
| Applied DNA Sciences Inc Quarterly EPS |
| 2025-03-31 |
$-230.14 |
| 2024-12-31 |
$-419.79 |
| 2024-09-30 |
$3,559.97 |
| 2024-06-30 |
$352.32 |
| 2024-03-31 |
$-3,979.76 |
| 2023-12-31 |
$-1,296.85 |
| 2023-09-30 |
$-3,988.01 |
| 2023-06-30 |
$-3,598.20 |
| 2023-03-31 |
$682.16 |
| 2022-12-31 |
$-4,497.75 |
| 2022-09-30 |
$899.55 |
| 2022-06-30 |
$-1,949.03 |
| 2022-03-31 |
$-3,448.28 |
| 2021-12-31 |
$-9,445.28 |
| 2021-09-30 |
$-7,496.25 |
| 2021-06-30 |
$-7,196.40 |
| 2021-03-31 |
$-3,148.43 |
| 2020-12-31 |
$-13,193.40 |
| 2020-09-30 |
$-10,344.82 |
| 2020-06-30 |
$-10,794.60 |
| 2020-03-31 |
$-11,844.08 |
| 2019-12-31 |
$-16,791.61 |
| 2019-09-30 |
$-10,044.97 |
| 2019-06-30 |
$-23,238.38 |
| 2019-03-31 |
$-48,275.86 |
| 2018-12-31 |
$-63,718.14 |
| 2018-09-30 |
$-237,780.80 |
| 2018-06-30 |
$-0.10 |
| 2018-03-31 |
$-0.07 |
| 2017-12-31 |
$-0.12 |
| 2017-09-30 |
$-0.10 |
| 2017-06-30 |
$-0.10 |
| 2017-03-31 |
$-0.13 |
| 2016-12-31 |
$-0.16 |
| 2016-09-30 |
$-0.10 |
| 2016-06-30 |
$-0.14 |
| 2016-03-31 |
$-0.14 |
| 2015-12-31 |
$-0.13 |
| 2015-09-30 |
$0.07 |
| 2015-06-30 |
$-0.08 |
| 2015-03-31 |
$-0.11 |
| 2014-12-31 |
$-0.51 |
| 2014-09-30 |
$-0.15 |
| 2014-06-30 |
$-0.14 |
| 2014-03-31 |
$-0.20 |
| 2013-12-31 |
$-0.48 |
| 2013-09-30 |
$-1.50 |
| 2013-06-30 |
$0.00 |
| 2013-03-31 |
$0.00 |
| 2012-12-31 |
$-0.01 |
| 2012-09-30 |
$0.00 |
| 2012-06-30 |
$0.00 |
| 2012-03-31 |
$0.00 |
| 2011-12-31 |
$0.00 |
| 2011-09-30 |
$-0.01 |
| 2011-06-30 |
$-0.01 |
| 2011-03-31 |
$-0.01 |
| 2010-12-31 |
$0.00 |
| 2010-09-30 |
$-0.01 |
| 2010-06-30 |
$-0.01 |
| 2010-03-31 |
$0.00 |
| 2009-12-31 |
$-0.01 |
| 2009-09-30 |
$-0.01 |
| 2009-06-30 |
$-0.01 |
| 2009-03-31 |
$0.04 |
| Sector |
Industry |
Market Cap |
Revenue |
| Industrial Products |
Protection - Safety Equipment & Services |
$0.002B |
$0.003B |
|
Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.
|
